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Autophagy is now recognized as a cellular defensemechanism that can restrict the growth ofMycobacterium
tuberculosis (Mtb). In this issue ofCell Host &Microbe, Kim et al. (2012) demonstrate that antibiotics routinely
used to treat Mtb infection elicit a host autophagy response critical for bacterial clearance.Mycobacterium tuberculosis (Mtb) is an
ancient human pathogen that is the
source of substantial disease and
economic burden. Treatment requires
long courses of antibiotic cocktails de-
signed to inhibit bacterial metabolism
and structural integrity. Despite extensive
efforts, a new drug with a novel mecha-
nism of action has not emerged since
1963 (Koul et al., 2011). This, coupled
with the emergence of multidrug-resistant
(MDR) and extremely drug-resistant (XDR)
tuberculosis (TB), has prompted identifi-
cation of cellular mechanisms that can
control intracellular Mtb. While originally
relegated to cellular housekeeping and
stress management, the host autophagy
pathway is now regarded as a critical
defense mechanism that can kill intra-
cellular Mtb (Deretic, 2011). During auto-
phagic elimination, molecular patterns
present in Mtb are recognized and the
bacterium is isolated within double
membrane autophaosomes. Fusion of
the autophagosome with a lysosome to
form the autolysosme exposes Mtb to
a toxic arsenal that destroys the bacte-
rium and liberates epitopes for immune
system recognition. As a result, host
autophagy directly and indirectly leads
to the killing of Mtb and thus inspires the
identification of compounds that can acti-
vate the autophagy pathway to eliminate
Mtb infection in humans.
A new report by Kim and colleagues in
the current issue of Cell Host & Microbe
(Kim et al., 2012) indicates that old antibi-
otics commonly used to treat Mtb infec-
tion have been inducing autophagy all
along. In this work, the authors clearly
demonstrate that two bactericidal first-
line drugs, isoniazid (INH) and pyrazina-
mide (PZA), enhance autophagy induced
in Mtb-infected macrophages. Antibi-
otic-boosted autophagy responses lead
to Mtb inclusion within the autophago-some, and this correlates with bacterial
killing. Treatment of genetically INH- or
PZA-resistant strains of Mtb with INH
and PZA, respectively, does not lead
to enhanced autophagy responses, sug-
gesting that bacterial stress or damage
is a prerequisite. These findings are
particularly relevant in light of the identifi-
cation of drug-resistant Mtb in 58 coun-
tries around the world and increased
prevalence in India, China, Russia, South
Africa, and Bangladesh (Lawn and Zumla,
2011). From these observations, it is
logical to hypothesize that MDR and
XDR strains of Mtb may also be resistant
to antibiotic-boosted autophagy. Confir-
mation that clinical MDR and XDR
strains are resistant to antibiotic-boosted
autophagy would reiterate the need and
challenge to identify small molecule
inducers that augment host autophagy
independent of the pathogen.
The authors report that the mechanism
by which INH and PZA boost autophagy
responses in Mtb-infected macrophages
involves reactive oxygen species (ROS)
and hydroxyl radicals generated by both
the host and pathogen. Hydroxyl radicals
produced by the bacteria in response to
INH and PZA stimulate the production of
cellular ROS. The net effect is the induc-
tion of an autophagy response that super-
sedes that produced by the bacterium
alone. This is an elegant mechanism that
highlights the dynamics between the
host and the pathogen and generates
exciting questions. Although the exact
mechanisms by which bacteria-derived
ROS stimulate the cellular ROS currently
remain unclear, the authors have shown
that cellular NADPH oxidase 2 (NOX2)
is a factor, as it is required for auto-
phagy induction. It is possible that ROS
produced by the bacterium can act as
a messenger to activate NOX2, a multisu-
bunit inducible enzyme that transfersCell Host & Microbeelectrons from NADPH to oxygen to
produce superoxide (Bedard and Krause,
2007). It is also reasonable to speculate
that bacteria-derived ROS serves to
liberate bacterial macromolecules that
can in turn stimulate cellular ROS and
autophagy. It has been demonstrated
that lipid material from mycobacteria is
a potent inducer of macrophage autoph-
agy (Zullo and Lee, 2012). Although INH
and PZA have different drug targets for
mycobacterial cell wall lipids and trans-
translation during the persisting nonrepli-
cating stage of Mtb, respectively (Shi
et al., 2011; Vilcheze and Jacobs, 2007),
both drug treatments were shown to
release bacterial ROS. Thus, it is feasible
that bacterial ROS generated by INH and
PZA treatment leads to release of stimula-
tory ligands, including lipids from the
mycobacterium. Once inside the host,
released bacterial products could lead to
the induction of cellular ROS that can acti-
vate the autophagy machinery. Additional
studies will be required to determine if
bacterial ROS is exclusively responsible
for cellular ROS generation, or if bacterial
components are involved as well.
Regardless of the mechanism, the
ability to generate a functional autophagy
response in response to antibiotic treat-
ment is critical to host defense. Using a
Drosophilamodel systemandM.marinum
as a representative mycobacterial path-
ogen, Kim et al. (2012) show that ablation
of autophagy by deletion of atg7, an
essential gene for autophagy, results in
a decreased response to antibiotic treat-
ment, as evidenced by survival and recov-
ered bacterial counts. While it remains to
be seen if the loss of autophagy in
a mouse model system reduces the
response to antibiotics, the work by Kim
et al. demonstrates in principle that the
ability to induce autophagy is critical for
optimal antibiotic efficacy. These findings11, May 17, 2012 ª2012 Elsevier Inc. 419
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genetic polymorphisms that impact au-
tophagy, as these could influence the
response to PZA/INH and the overall clin-
ical outcome. This report also highlights
the need for rapid and precise resistance
genotyping of Mtb isolates in the field.
While it is not clear if each antibiotic can
boost autophagy responses, it would be
ideal to utilize the most bactericidal
combination to engage the autophagy
pathway, as bacteriostatic agents were
not found to boost autophagy in similar
assays.
Infection with Mtb is well known to elicit
a potent inflammatory cytokine response
that is largely responsible for the disease
pathology. Evidence from several groups
has identified that cytokine production
can in part be regulated by autophagy.
In the current study, treatment of Mtb-in-
fected cells with INH reduced the produc-
tion of inflammatory cytokines TNF-a,
IL-6, and IL-1b. Furthermore, blocking
autophagy induction in Mtb-infected cells
treated with INH resulted in enhanced
inflammatory cytokine production. From
these data, one can speculate that bacte-
rial killing by autophagy and inflammatory
cytokine production are tightly coupled420 Cell Host & Microbe 11, May 17, 2012 ª2such that as bacteria are destroyed,
the need for inflammatory cytokines is
reduced. Since inflammatory cytokines
are themselves autophagy inducers, the
data presented by Kim et al. (2012)
persuasively suggest how autophagic
killing and cytokine production could
regulate each other to achieve a balance
that bolsters host defense and limits cyto-
kine-induced pathology. It is also inter-
esting to consider that exuberant cytokine
production during Mtb treatment may
itself be diagnostic of a weak autophagy
response and poor long-term prognosis.
Additional studies will be necessary to
examine this correlation as the potential
to be a valuable clinical tool.
As we can continue to mine for new
antibiotics that can treat Mtb infection,
we should keep in mind that medicines
that are decades old have been exploiting
a newly appreciated cellular defense
mechanism. Clearly, an ideal antibiotic
would target a bacterial Achilles’ heel
but also enhance the activity of endoge-
nous cellular defenses such as autoph-
agy. It may also be possible to combine
antibiotics with agents that act specifi-
cally on the host autophagy pathway to
produce combination therapies. Large-012 Elsevier Inc.scale chemical screens have begun to
identify mammalian target of rapamycin
(mTOR)-independent agents that may
serve this purpose and avoid the immuno-
suppressive effects of rapamycin or
similar agents. The current work demon-
strates that focusing therapy on both the
host and the pathogen would be an ideal
combination to strive for in the future.
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Mitochondria are dynamic organelles with many functions. In this issue of Cell Host & Microbe, Kramer and
Enquist (2012) show that mitochondrial motility and morphology are disrupted during alphaherpesvirus
infection, which aids viral replication and transport in neurons.Mitochondria have many functions in in-
fected and noninfected cells, including
energy generation, calcium homeostasis,
innate immune signaling, and apoptosis.
Disruption of mitochondrial function may
help also drive neurodegeneration and
contribute to Alzheimer’s disease, Parkin-
son’s disease, and amyotrophic lateralsclerosis (ALS) (Detmer and Chan, 2007).
Mitochondria are dynamic organelles,
and their movement is mediated by
microtubules and dynein/kinesin motor
systems. Alphaherpesviruses encode
proteins that alter mitochondrial localiza-
tion and function, primarily to reduce
apoptosis (Pomeranz et al., 2005). How-ever, the mechanisms underlying virus-
mediated alteration of mitochondrial
dynamics are unclear, particularly in
neurons.
Neurons are unique cells due to their
electrical activity and length, which re-
quires long-distance transport of car-
goes including organelles and viruses.
